Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
about
Cardiac regulation by phosphoinositide 3-kinases and PTENUse of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.Did clinical trials in which erythropoietin failed to reduce acute myocardial infarct size miss a narrow therapeutic window?Pharmacotherapy for end-stage coronary artery disease.Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin.Cardioprotective effect of erythropoietin on sepsis-induced myocardial injury in rats.Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver.Effect of erythropoietin levels on mortality in old age: the Leiden 85-plus StudyEarly sustained injections of erythropoietin improve angiogenesis and restoration of perfusion in the ischemic mouse hindlimb.Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.Anemia and heart failure: a cause of progression or only a consequence?Erythropoietin Reduces Post-PCI Arrhythmias in Patients With ST-elevation Myocardial Infarction.Erythropoietin gene delivery using an arginine-grafted bioreducible polymer system.Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes.Acute hemodynamic effects of erythropoietin do not mediate its cardioprotective properties.Pharmacologic therapeutics for cardiac reperfusion injury.Internal medicine, renal anaemia, and erythropoiesis-stimulating agents (ESAS).Circulating levels of erythropoietin and its relation to arterial stiffness in patients with hypertensionHuman erythropoietin gene delivery for cardiac remodeling of myocardial infarction in ratsG-CSF- and erythropoietin-based cell therapy: a promising strategy for angiomyogenesis in myocardial infarction.The role of erythropoietin as an inhibitor of tissue ischemia.Effects of erythropoietin on electrocardiogram changes in carbon monoxide poisoning: an experimental study in ratsProtein engineering for cardiovascular therapeutics: untapped potential for cardiac repair.Anemia in heart failure: pathophysiologic insights and treatment options.Emerging technologies in the delivery of erythropoietin for therapeutics.Is there a role for erythropoietin in cardiovascular disease?Diverse effects of statins on angiogenesis: new therapeutic avenues.Prevention and treatment of no-reflow.Erythropoiesis-stimulating agents and heart failure.Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.Therapeutic gene delivery using bioreducible polymers.Cardiac regeneration: current therapies-future concepts.Functional polymers of gene delivery for treatment of myocardial infarct.The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.Myocardial protection from ischemia-reperfusion injury post coronary revascularization.Angiogenic growth factors in myocardial infarction: a critical appraisal.Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium.Cardiac antiapoptotic and proproliferative effect of recombinant human erythropoietin in a moderate stage of chronic renal failure in the rat.
P2860
Q24317248-5F30DA81-E326-49AA-A3BD-A2900B9FF794Q30486662-AF452159-50B6-416B-BC76-E422B09894EBQ30539892-CB2D0AD4-3EAC-48EF-9276-6BE775E15C41Q31056941-877B588F-6207-412C-A7AC-FD0727775AF0Q33610142-772BE876-D792-4F24-B37F-2FD842DED698Q33750384-8F343C0C-63DE-42BA-B2B0-1CCE2C05319AQ34032253-2845C431-12A1-4945-9D52-601C79184037Q34200868-0025B98F-AF27-4F73-AAF1-EDFA21A69989Q34403856-30286D33-A92C-404D-8874-4A96F34BE069Q34411778-E623CA6E-006B-4E3D-8815-1906D63F9BA3Q34479931-1F830941-5601-4BB6-B625-7987F2789C00Q35252704-9D995E61-F88A-4839-ACB1-A395F3F1A7A2Q35705440-517ECD03-C55D-4D52-8B9F-FE1E72F68B12Q35751347-3473501D-4E19-4000-940C-F474450C0429Q36364317-8B2DEEB8-9178-4A53-B97E-71CB35F849E6Q36392857-E12B6C6C-7A69-4BE0-8A94-819A42574E56Q36425514-576B1DB9-5855-4EF8-91A7-CCD487EFDC40Q36944008-F4BFBD4D-AAB6-4B3E-A6EE-E6F6EA82553FQ37113720-AF3989A8-A9C3-4DA4-8249-4F4A4B373E63Q37146335-D735C9F5-E40F-41D7-944B-EE3CEABFB20AQ37158904-D828D5EE-9E02-4957-BD1C-85B0749A413EQ37176449-1A353900-C4DF-4A3D-8B0C-8160B5D60BB7Q37195742-763C4855-2C38-4FB8-A192-C95FC8416BA9Q37268268-8246A3E8-6292-4BB1-BADA-1732BB24ADE9Q37405644-3264411C-6BF4-4028-AB5D-F0DC2985ED20Q37445907-6C682FAD-28BC-4D71-AC2C-CCF7861E75DDQ37646523-A4A46FB1-FC6D-4D22-9EDA-275187C1775CQ37661050-D96CD679-D064-4FEB-B78F-DE032A27401DQ37680944-DC5A31A8-4B2B-4159-8E74-BD2F0670AFA5Q37779094-A1EBFEB6-8238-428A-A1D8-BD0B1B941765Q37802925-96F91167-B10F-448F-B6AB-27E616C7ADBBQ37883005-A847E38B-E2FA-4400-8E1A-5775BB645D5CQ38157750-E3E28D2A-E2E1-49F0-B447-C48EF344614FQ38164335-12989AAB-7ED5-4413-BB97-8FC6C6A4CA47Q38235326-B31D7B7A-5261-4130-A588-69EED9DFB1B4Q38399783-912CFED7-4A20-4929-B753-6A59CFB1FE73Q38552442-01BE4DCF-A163-4E94-AE72-D477E22E338CQ39389842-9BC83943-9D6D-40E8-BDB7-3B64AD3C4494Q40610492-47A1ECD3-CD08-403A-A569-15B5095414ADQ41398632-D3DE7DEE-C978-4BD0-9C49-7EFD88F0221E
P2860
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
@ast
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
@en
type
label
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
@ast
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
@en
prefLabel
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
@ast
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
@en
P2093
P1476
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
@en
P2093
Adriaan A Voors
Erik Lipsic
Peter van der Meer
Regien G Schoemaker
Wiek H van Gilst
P304
P356
10.1016/J.JACC.2006.08.031
P407
P577
2006-11-09T00:00:00Z